CEP162 (centrosomal protein 162)
|
Gene
Gene information from NCBI Gene database.
|
|
| Entrez ID | 22832 |
| Gene name | Centrosomal protein 162 |
| Gene symbol | CEP162 |
| Synonyms (NCBI Gene) |
C6orf84KIAA1009QN1
|
| Chromosome | 6 |
| Chromosome location | 6q14.2-q14.3 |
|
miRNA
miRNA information provided by mirtarbase database.
36
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene Ontology (GO) annotations describing the biological processes, molecular functions, and cellular components associated with a gene.
23
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other IDs provides unique identifiers for this gene in OMIM, HGNC, and Ensembl databases.
|
|||||||
|
|||||||
|
Protein
Protein information from UniProt database.
|
||
|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
Q5TB80 | |
| Protein name | Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog) | |
| Protein function | Required to promote assembly of the transition zone in primary cilia. Acts by specifically recognizing and binding the axonemal microtubule. Localizes to the distal ends of centrioles before ciliogenesis and directly binds to axonemal microtubul | |
| Family and domains | ||
| Sequence |
|
|
| Sequence length | 1403 | |
| Interactions | View interactions | |
|
Pathways
Pathway information has different metabolic/signaling pathways associated with genes.
|
|||||||
|
|||||||
|
Associated diseases
Disease associations from ClinVar (causal & non-causal) and other databases (OMIM, Orphanet, GWAS, etc.).
5
|
|||||||||||||||||||||||||
|
Evidence Score:
★☆☆☆☆ Gene-disease association found in Text Mining only
★★☆☆☆ Found in Text Mining and Unknown/Other Associations
★★★☆☆ Reported in Unknown/Other Associations across ≥2 Sources
★★★★☆ ClinVar: Pathogenic/Likely Pathogenic (<5 Variants)
★★★★★ ClinVar: Pathogenic/Likely Pathogenic (≥5 Variants)
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||